These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32345379)

  • 41. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bone disease in multiple myeloma. A study of 237 cases].
    Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
    Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective Evaluation of Magnetic Resonance Imaging and [
    Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
    J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of observer variation in measuring the Radiographic Vertebral Index in patients with multiple myeloma.
    Browman GP; Markman S; Thompson G; Minuk T; Chirawatkul A; Roberts RS
    J Clin Epidemiol; 1990; 43(8):833-40. PubMed ID: 2384769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone densitometry in patients with multiple myeloma.
    Mariette X; Khalifa P; Ravaud P; Frija J; Laval-Jeantet M; Chastang C; Brouet JC; Fermand JP
    Am J Med; 1992 Dec; 93(6):595-8. PubMed ID: 1466354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current role of CT and whole body MRI in multiple myeloma.
    Duvauferrier R; Valence M; Patrat-Delon S; Brillet E; Niederberger E; Marchand A; Rescan M; Guillin R; Decaux O
    Diagn Interv Imaging; 2013 Feb; 94(2):169-83. PubMed ID: 23298944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of 18F-fluoride PET/CT in the assessment of multiple myeloma: initial experience.
    Nishiyama Y; Tateishi U; Shizukuishi K; Shishikura A; Yamazaki E; Shibata H; Yoneyama T; Ishigatsubo Y; Inoue T
    Ann Nucl Med; 2013 Jan; 27(1):78-83. PubMed ID: 22914967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Computerized tomography of the spine in the evaluation of multiple myeloma].
    Pozzi Mucelli RS; Pozzi Mucelli F; Morassi P; Gozzi G; Magnaldi S
    Radiol Med; 1988 Apr; 75(4):291-6. PubMed ID: 3375473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images.
    Homann G; Weisel K; Mustafa DF; Ditt H; Nikolaou K; Horger M
    Skeletal Radiol; 2015 Jul; 44(7):971-9. PubMed ID: 25833276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of osteoporosis (as measured by lumbar spine quantitative computed tomography) on disease activity and survival in myeloma patients: a 13-year prospective study.
    Diamond T; Golombick T; Manoharan A; Kwan Y; Bryant C
    Am J Hematol; 2011 Jul; 86(7):617-9. PubMed ID: 21544858
    [No Abstract]   [Full Text] [Related]  

  • 55. Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.
    Simeone FJ; Harvey JP; Yee AJ; O'Donnell EK; Raje NS; Torriani M; Bredella MA
    Skeletal Radiol; 2019 May; 48(5):773-779. PubMed ID: 30218303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and first validation of a simplified CT-based classification system of soft tissue changes in large-head metal-on-metal total hip replacement: intra- and interrater reliability and association with revision rates in a uniform cohort of 664 arthroplasties.
    Boomsma MF; Edens MA; Van Lingen CP; Warringa N; Ettema HB; Verheyen CC; Maas M
    Skeletal Radiol; 2015 Aug; 44(8):1141-9. PubMed ID: 25943898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
    Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L
    J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma; Methodological issues on Diagnostic value.
    Sabour S
    Br J Haematol; 2018 Aug; 182(4):605-606. PubMed ID: 28737210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.